Westpac Banking Corp
WBC
CommBank
CBA
Fortescue Ltd
FMG
Rio Tinto Ltd
RIO
National Australia Bank Ltd
NAB
AU Stock MarketDetailed Quotes
CUV Clinuvel Pharmaceuticals Ltd
- 12.460
- +0.310+2.55%
20min DelayMarket Closed Dec 27 16:00 AET
623.76MMarket Cap17.85P/E (Static)
12.500High12.140Low65.23KVolume12.140Open12.150Pre Close807.02KTurnover17.65252wk High0.16%Turnover Ratio50.06MShares11.71552wk Low0.698EPS TTM515.47MFloat Cap45.422Historical High17.85P/E (Static)41.37MShs Float0.173Historical Low0.698EPS LYR2.96%Amplitude0.05Dividend TTM3.07P/B1Lot Size0.40%Div YieldTTM
Clinuvel Pharmaceuticals Ltd Key Stats
Quarterly+Annual
YOY
| (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | (FY)Jun 30, 2018 | (FY)Jun 30, 2017 | (FY)Jun 30, 2016 | (FY)Jun 30, 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 12.59%88.18M | 19.17%78.32M | 36.99%65.72M | 47.32%47.98M | 4.89%32.57M | 21.82%31.05M | 52.42%25.49M | 169.19%16.72M | 113.33%6.21M | 32.34%2.91M |
| Operating revenue | 12.59%88.18M | 19.17%78.32M | 36.99%65.72M | 47.32%47.98M | 4.89%32.57M | 21.82%31.05M | 52.42%25.49M | 169.19%16.72M | 113.33%6.21M | 32.34%2.91M |
| Cost of revenue | 14.70%10.08M | -16.16%8.79M | 122.10%10.48M | -50.98%4.72M | 40.14%9.63M | 14.80%6.87M | 47.68%5.99M | 8.52%4.05M | 43.48%3.73M | -20.10%2.6M |
| Gross profit | 12.32%78.1M | 25.88%69.53M | 27.70%55.24M | 88.59%43.26M | -5.13%22.94M | 23.98%24.18M | 53.94%19.5M | 411.49%12.67M | 702.49%2.48M | 129.18%308.61K |
| Operating expense | 18.33%30.09M | 27.73%25.43M | 32.45%19.91M | 30.19%15.03M | 49.94%11.55M | 4.72%7.7M | 23.23%7.35M | -10.42%5.97M | -42.42%6.66M | 119.41%11.57M |
| Selling and administrative expenses | 10.89%25.03M | 27.41%22.57M | 38.81%17.71M | 575.61%12.76M | 25.75%1.89M | 42.89%1.5M | -81.54%1.05M | -10.60%5.69M | -43.68%6.37M | 123.62%11.31M |
| -Selling and marketing expense | ---- | ---- | ---- | ---- | 25.75%1.89M | 42.89%1.5M | 29.54%1.05M | 4.33%811.43K | -2.97%777.73K | 55.30%801.56K |
| -General and administrative expense | 10.89%25.03M | 27.41%22.57M | 38.81%17.71M | --12.76M | ---- | ---- | ---- | -12.68%4.88M | -46.79%5.59M | 131.38%10.51M |
| Depreciation amortization depletion | 44.71%1.14M | 4.17%789.41K | -12.03%757.83K | 101.44%861.43K | 99.67%427.63K | 380.80%214.16K | -16.17%44.54K | 108.17%53.14K | -3.82%25.53K | -29.18%26.54K |
| -Depreciation and amortization | 44.71%1.14M | 4.17%789.41K | -12.03%757.83K | 101.44%861.43K | 99.67%427.63K | 380.80%214.16K | -16.17%44.54K | 108.17%53.14K | -3.82%25.53K | -29.18%26.54K |
| Other operating expenses | 89.25%3.92M | 44.07%2.07M | 2.10%1.44M | -84.73%1.41M | 54.23%9.23M | -4.37%5.98M | 2,747.85%6.26M | -17.42%219.71K | 14.61%266.07K | 30.78%232.15K |
| Operating profit | 8.85%48.01M | 24.83%44.1M | 25.18%35.33M | 147.79%28.22M | -30.87%11.39M | 35.64%16.48M | 81.29%12.15M | 260.14%6.7M | 62.84%-4.18M | -77.87%-11.26M |
| Net non-operating interest income (expenses) | 302.53%2.87M | 138.96%713.14K | -43.41%-1.83M | -337.64%-1.28M | -1.20%537.04K | 105.54%543.54K | 0.02%264.45K | 26.89%264.39K | -40.19%208.37K | 6.72%348.41K |
| Non-operating interest income | 87.54%7.32M | 779.56%3.91M | 29.77%444.07K | -39.21%342.2K | -0.31%562.93K | 113.52%564.66K | 0.02%264.45K | 26.89%264.39K | -40.19%208.37K | 6.72%348.41K |
| Non-operating interest expense | 39.51%4.45M | 40.38%3.19M | 40.53%2.27M | 6,152.14%1.62M | 22.60%25.89K | --21.11K | ---- | ---- | ---- | ---- |
| Other net income (expenses) | -125.87%-197.44K | -7.07%763.08K | 166.46%821.15K | -258.14%-1.24M | -11.26%781.32K | 81.23%880.48K | 405.48%485.84K | -87.93%96.11K | 69.38%796.53K | 6.78%470.27K |
| Other non-operating income (expenses) | -125.87%-197.44K | -7.07%763.08K | 166.46%821.15K | -258.14%-1.24M | -11.26%781.32K | 81.23%880.48K | 405.48%485.84K | -87.93%96.11K | 69.38%796.53K | 6.78%470.27K |
| Income before tax | 11.19%50.68M | 32.80%45.58M | 33.48%34.32M | 95.73%25.71M | -27.48%13.14M | 39.96%18.11M | 81.92%12.94M | 325.58%7.11M | 69.72%-3.15M | -88.47%-10.41M |
| Income tax | 0.46%15.04M | 11.39%14.97M | 1,265.55%13.44M | 128.04%984.4K | -18,057.49%-3.51M | 93.14%-19.33K | -281.78K | 0 | 0 | 0 |
| Earnings from equity interest net of tax | ||||||||||
| Net income | 16.44%35.64M | 46.58%30.6M | -15.57%20.88M | 48.55%24.73M | -8.20%16.65M | 37.13%18.13M | 85.88%13.22M | 325.58%7.11M | 69.72%-3.15M | -88.47%-10.41M |
| Net income continuous operations | 16.44%35.64M | 46.58%30.6M | -15.57%20.88M | 48.55%24.73M | -8.20%16.65M | 37.13%18.13M | 85.88%13.22M | 325.58%7.11M | 69.72%-3.15M | -88.47%-10.41M |
| Noncontrolling interests | -66.54K | |||||||||
| Net income attributable to the company | 16.44%35.64M | 46.58%30.6M | -15.57%20.88M | 48.55%24.73M | -8.20%16.65M | 37.13%18.13M | 84.16%13.22M | 327.69%7.18M | 69.72%-3.15M | -88.47%-10.41M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 16.44%35.64M | 46.58%30.6M | -15.57%20.88M | 48.55%24.73M | -8.20%16.65M | 37.13%18.13M | 84.16%13.22M | 327.69%7.18M | 69.72%-3.15M | -88.47%-10.41M |
| Diluted earnings per share | 15.51%0.715 | 46.34%0.619 | -15.40%0.423 | 47.93%0.5 | -10.11%0.338 | 35.74%0.376 | 85.91%0.277 | 312.86%0.149 | 70.83%-0.07 | -67.83%-0.24 |
| Basic earnings per share | 18.10%0.698 | 46.65%0.591 | -16.74%0.403 | 46.67%0.484 | -9.84%0.33 | 37.08%0.366 | 86.71%0.267 | 304.29%0.143 | 70.83%-0.07 | -67.83%-0.24 |
| Dividend per share | 25.00%0.05 | 60.00%0.04 | 0.00%0.025 | 0.00%0.025 | 25.00%0.025 | 0.02 | ||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
